Meeting to be held on June 23-24 hosted by Oppenheimer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRIX:
- Promising Developments in Nurix Therapeutics’ BTK Degrader Drive Buy Rating
- Nurix Therapeutics Announces Positive Phase 1 Trial Results
- Nurix Therapeutics presents updated data from ongoing trial of bexobrutideg
- Optimistic Outlook on Nurix Therapeutics: Strategic Partnerships and Financial Gains Drive Buy Rating
- Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6